A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy

NCT04455750 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Castration-Resistant Prostate Carcinoma
Metastatic Prostate Adenocarcinoma
Stage IV Prostate Cancer AJCC v8
Stage IVA Prostate Cancer AJCC v8
Stage IVB Prostate Cancer AJCC v8

Interventions

DRUG: Enzalutamide
DRUG: Rucaparib camsylate
DRUG: Placebo
DRUG: Leuprolide Acetate
DRUG: Goserelin Acetate
DRUG: Degarelix
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]